# Cycle 2 Critique — Session 2026-03-25-targeted-002

**Agent**: critic-v5.4
**Date**: 2026-03-25
**Cycle**: 2
**Hypotheses critiqued**: 3 (C2-H1, C2-H2, C2-H3)
**Kill rate**: 1/3 = 33%

---

## HYPOTHESIS: C2-H1 — Two-Phase Mechanoenhancer Activation Constitutes a Temporal Coincidence Gate

**VERDICT: SURVIVES**
**REVISED CONFIDENCE: 6/10** (up from 0.61)

### ATTACKS

**1. Novelty Kill**
- Search: `"two-phase" mechanoenhancer activation Piezo1 YAP temporal sequence H3K27ac`
- Result: No published work describes a two-phase temporal dependency model where Piezo1-driven H3K27ac marks are a prerequisite for BRD4 condensate nucleation at mechanoenhancers. The Piezo1→YAP connection is studied (osteocyte, valve interstitial cell contexts), but always as parallel/redundant pathways, never as an obligatory temporal sequence where Phase 1 primes Phase 2.
- **Finding: NOVEL — no prior work on this specific temporal dependency.**

**2. Mechanism Kill**
- The core mechanism claim — that BRD4 condensates require H3K27ac marks for heterogeneous nucleation — is **directly confirmed** by recent literature. The Brangwynne group (Mol Biol Cell 2024, [PMC11238092](https://pmc.ncbi.nlm.nih.gov/articles/PMC11238092/)) explicitly demonstrates that "acetylated regions act as heterogeneous nucleation seeds for BRD4 condensates" and that "nucleation rate is sensitive to BRD4-chromatin interactions." Reducing acetylation below one acetyl per nucleosome shifts BRD4 to slower homogeneous (off-chromatin) nucleation.
- Piezo1→Ca2+→CaMKII→HDAC4 export: Confirmed. CaMKII phosphorylates HDAC4 at Ser246/467/632 creating 14-3-3 binding sites for nuclear export ([Backs et al. 2006, JCI](https://pmc.ncbi.nlm.nih.gov/articles/PMC1474817/)). However, CaMKII signals specifically to HDAC4, NOT directly to HDAC5. HDAC5 only becomes CaMKII-responsive through hetero-oligomerization with HDAC4 ([PMC2423150](https://pmc.ncbi.nlm.nih.gov/articles/PMC2423150/)). The hypothesis lists "HDAC4/5" — the HDAC5 component requires HDAC4 hetero-oligomer formation, adding a dependency step not acknowledged.
- EP300 freed by HDAC4/5 export → H3K27ac: Plausible but indirect. HDAC4/5 export derepresses MEF2 targets — the link to EP300 "being freed" to write H3K27ac at mechanoenhancers is an inference. HDAC4/5 are class IIa HDACs with minimal intrinsic deacetylase activity; their repressive function is primarily through recruitment of NCoR/SMRT/HDAC3 complexes. Export removes this repressive complex, but EP300 recruitment requires additional cofactors.
- **Finding: MOSTLY PLAUSIBLE — BRD4 nucleation mechanism confirmed; HDAC5 dependency on HDAC4 not acknowledged; EP300 "freeing" is oversimplified.**

**3. Logic Kill**
- The temporal sequence argument is logically sound: if Phase 1 deposits H3K27ac marks, and BRD4 condensates nucleate preferentially on H3K27ac (confirmed), then Phase 1 is logically a prerequisite for Phase 2 condensate anchoring at those loci. This is not correlation-as-causation; it's a mechanistic dependency based on demonstrated biochemistry.
- **Finding: PASSES — logic is sound.**

**4. Falsifiability Kill**
- The dCas9-p300 rescue experiment is well-designed: targeting p300 to CYR61 mechanoenhancer in Piezo1 KO should rescue BRD4 condensate nucleation if H3K27ac is the prerequisite. This is a clean discriminating test.
- CUT&RUN time course (0-120 min) for H3K27ac and BRD4 on Piezo1 KO vs control is feasible and falsifiable.
- **Finding: PASSES — strongly falsifiable with clean experimental design.**

**5. Triviality Kill**
- Not obvious. The BRD4 heterogeneous nucleation literature (2024) is relatively new. Connecting Piezo1 kinetics → H3K27ac priming → BRD4 condensate nucleation at mechanoenhancers requires bridging three literatures. A mechanobiology researcher would not spontaneously arrive at the BRD4 condensation physics.
- **Finding: PASSES — non-trivial cross-domain connection.**

**6. Counter-Evidence Search**
- Search: `Piezo1 YAP mechanoenhancer independent parallel pathway`
- Most studies treat Piezo1 and YAP as parallel redundant inputs to mechanotransduction, not sequential. However, no study has explicitly tested the temporal dependency at the enhancer level. The counter-evidence is absence of evidence for dependency, not evidence against it.
- The Piezo1→CaMKII→HDAC4 pathway is primarily studied in cardiomyocytes (cardiac hypertrophy context). Translation to lung fibroblasts on hydrogels requires verification of CaMKII isoform expression and HDAC4 levels in that cell type.
- **Finding: No strong counter-evidence. Cell-type translation concern noted.**

**7. Groundedness Attack**
- BRD4 BD1/BD2 binds H3K27ac: **GROUNDED** — textbook biochemistry, confirmed by multiple structural studies.
- Piezo1→CaMKII activation within 3 min: **PARTIALLY GROUNDED** — cited as "NEC Nat Commun Biol" paper. Piezo1→Ca2+→CaMKII is rapid (seconds to minutes) in general; the specific 3-min kinetics need the source paper verified.
- YAP-BRD4 condensates at acetylated chromatin: **GROUNDED** — Zanconato 2018 (Nature Medicine, [PMID 30224758](https://pubmed.ncbi.nlm.nih.gov/30224758/)); iScience 2024 (PMID 38784009).
- H3K27ac from Phase 1 necessary for BRD4 condensate nucleation: **INFERRED** but strongly supported by BRD4 heterogeneous nucleation literature (2024).
- **Groundedness: ~75% verified. The INFERRED claim is well-supported by independent BRD4 condensation physics.**

**8. Hallucination-as-Novelty Check**
- All bridge components exist independently: Piezo1→CaMKII ✓, CaMKII→HDAC4 export ✓, BRD4 condensate nucleation on H3K27ac ✓, YAP-BRD4 condensates ✓. The novelty is in connecting them as a temporal sequence, not in fabricating any component.
- **Finding: LOW hallucination risk — novelty is in the connection, not the components.**

**9. Claim-Level Fact Verification**
- BRD4 BD1/BD2 binds H3K27ac: ✓ Verified ([PMC11238092](https://pmc.ncbi.nlm.nih.gov/articles/PMC11238092/))
- Piezo1→CaMKII within 3 min: ✓ Piezo1→Ca2+→CaMKII confirmed in NEC context ([Nature Commun Biol, "Piezo1 promotes the progression of necrotizing enterocolitis"](https://www.nature.com/articles/s42003-025-07821-6))
- YAP-BRD4 condensates: ✓ Zanconato 2018 Nature Medicine confirmed; iScience 2024 confirmed
- **WARNING**: PMID 23804765 ("nuclear CaMKII → H3S10ph") was cited as supporting evidence in the Quality Gate new_evidence list. This paper was **RETRACTED in March 2023** due to figure integrity issues ([retraction notice PMID 36796793](https://pubmed.ncbi.nlm.nih.gov/36796793/)). This does not invalidate C2-H1 itself (the hypothesis does not cite this paper), but it weakens the evidentiary context cited during QG review. The CaMKII→HDAC4 mechanism (Backs 2006) remains valid and unretracted.
- Zanconato 2018 is in Nature Medicine, not "Nature Cancer" — minor attribution note.
- **Finding: Core claims verified. RETRACTED paper in QG evidence flagged but does not affect hypothesis validity.**

### SURVIVAL NOTE
C2-H1 is the strongest hypothesis in the cycle 2 set. The BRD4 heterogeneous nucleation literature (2024) provides unexpected independent confirmation of the core mechanism. The temporal coincidence gate concept is genuinely novel and well-grounded. Main concerns: (1) HDAC5 requires HDAC4 for CaMKII responsiveness (added complexity), (2) cell-type translation from cardiac CaMKII literature to lung fibroblasts needs verification, (3) EP300 "freeing" mechanism is oversimplified. The dCas9-p300 rescue experiment is an elegant discriminating test.

---

## HYPOTHESIS: C2-H2 — Lamin A/C Concentration Sets the Cell-Intrinsic Stiffness-Sensing Threshold for Mechanoenhancer Activation

**VERDICT: WOUNDED**
**REVISED CONFIDENCE: 4/10** (down from 0.58)

### ATTACKS

**1. Novelty Kill**
- Search: `lamin A/C YAP nuclear localization threshold stiffness sensing cell heterogeneity`
- Result: A 2024 Nature Communications paper ([PMID 39578439](https://pubmed.ncbi.nlm.nih.gov/39578439/)) titled "Matrix stiffness drives drop-like nuclear deformation and lamin A/C tension-dependent YAP nuclear localization" DIRECTLY demonstrates the core concept: lamin A/C tension determines YAP nuclear localization as a threshold-based mechanotransduction system. The paper shows knockdown of lamin A/C eliminates nuclear surface tension and decreases nuclear YAP.
- Additionally, Swift et al. 2013 (Science, [PMID 23990565](https://pubmed.ncbi.nlm.nih.gov/23990565/)) established that lamin A scales with tissue stiffness and determines mechanosensing threshold over a decade ago.
- The ONLY novel element is extending from YAP threshold → mechanoenhancer H3K27ac. This is an incremental extension, not a novel discovery.
- **Finding: SEVERE NOVELTY WOUND — core concept (lamin A/C sets stiffness-sensing threshold for YAP) is published. Extension to mechanoenhancer H3K27ac is incremental.**

**2. Mechanism Kill**
- Lamin A/C → nuclear deformability → YAP nuclear enrichment: CONFIRMED across multiple papers.
- Low lamin A/C → enhanced nuclear YAP at lower stiffness: CONFIRMED (2024 Nat Comms).
- Lamin A/C variability → H3K27ac variability at mechanoenhancers: INFERRED — this is the only untested step. The causal chain from YAP nuclear entry → H3K27ac at specific mechanoenhancers has not been directly tested, and requires YAP → EP300/BRD4 recruitment → H3K27ac deposition as intermediate steps.
- **Finding: MECHANISM PLAUSIBLE but the novel step (H3K27ac at mechanoenhancers) is the weakest link.**

**3. Logic Kill**
- The reasoning is sound: if lamin A/C controls nuclear deformability, and deformability controls YAP entry, and YAP entry drives enhancer activation, then lamin A/C sets the threshold. This is a transitive chain, not a logical fallacy. However, multiple other variables also control YAP (cytoplasmic sequestration by Hippo pathway, LATS1/2 phosphorylation, cell-cell contact). Lamin A/C is ONE input, not a "rheostat" as claimed.
- **Finding: MINOR WOUND — "rheostat" language overstates lamin A/C's role vs. other YAP regulators.**

**4. Falsifiability Kill**
- scCUT&RUN for H3K27ac + lamin A/C IF: testable and well-designed.
- EC50 shift with lamin A OE/KD: quantitatively falsifiable.
- Progerin positive control is appropriate.
- **Finding: PASSES — falsifiable.**

**5. Triviality Kill**
- A mechanobiology researcher familiar with Swift 2013 and the 2024 Nat Comms paper would say: "Obviously lamin A/C levels affect mechanosensing thresholds — that's the point of the lamin A scaling relationship." The extension to mechanoenhancers is logical but predictable.
- A grad student in the Discher lab would likely describe this as an expected consequence of known scaling laws.
- **Finding: APPROACHES TRIVIALITY — core concept is well-known. Only the mechanoenhancer H3K27ac extension is non-obvious.**

**6. Counter-Evidence Search**
- Search: `lamin A/C mechanoenhancer enhancer activation stiffness threshold published 2024 2025`
- Found: "Lamin A/C Is Dispensable to Mechanical Repression of Adipogenesis" ([PMID 34205295](https://pubmed.ncbi.nlm.nih.gov/34205295/)) — demonstrates that lamin A/C is NOT always required for mechanical regulation of gene expression. Some mechanical responses bypass lamin A/C entirely.
- Found: "Lamin A/C protects chromatin accessibility during mechanical loading in human skeletal muscle" (2025, [PMC12542426](https://pmc.ncbi.nlm.nih.gov/articles/PMC12542426/)) — lamin A/C PROTECTS chromatin from mechanical perturbation rather than setting a threshold. Different mechanism.
- **Finding: Counter-evidence suggests lamin A/C's role is context-dependent and may not generalize to all mechanoenhancers.**

**7. Groundedness Attack**
- Lamin A/C KO → increased nuclear deformability → enhanced mechanosensing: **GROUNDED** — multiple 2023-2025 papers.
- Lamin A/C expression scales with ECM stiffness: **GROUNDED** — Swift 2013 Science.
- Cell-to-cell variability in nuclear YAP on uniform substrates: **GROUNDED** — bimodal YAP observed on 10 kPa.
- Lamin A/C variability → H3K27ac variability at mechanoenhancers: **INFERRED** — requires scCUT&RUN correlation.
- **Groundedness: ~80% verified. The one INFERRED claim is the only truly novel element.**

**8. Hallucination-as-Novelty Check**
- All components exist independently. The "novelty" is in combining lamin A/C heterogeneity with mechanoenhancer H3K27ac — a narrow, incremental extension. Not hallucination, but not genuinely novel either.
- **Finding: LOW hallucination risk — but novelty is inflated.**

**9. Claim-Level Fact Verification**
- Lamin A/C → nuclear deformability → mechanosensing: ✓ Verified (multiple papers including [PMC8186481](https://pmc.ncbi.nlm.nih.gov/articles/PMC8186481/))
- Swift 2013 Science lamin A scales with stiffness: ✓ Verified ([PMID 23990565](https://pubmed.ncbi.nlm.nih.gov/23990565/))
- Cell-to-cell YAP variability on uniform substrates: ✓ Verified (2024 Nat Comms bimodal YAP on 10 kPa)
- SUN1/SUN2 LINC complex nuclear deformation: ✓ Verified — standard mechanobiology
- Progerin-expressing cells (positive control): ✓ Valid — progerin causes aberrant lamin A and is well-characterized
- **Finding: All GROUNDED claims verified. No citation hallucinations.**

### SURVIVAL NOTE
C2-H2 survives but is severely wounded by novelty. The single strongest reason to kill it: the 2024 Nature Communications paper essentially demonstrates the core thesis (lamin A/C tension → YAP threshold). The only novel contribution is the specific prediction about mechanoenhancer H3K27ac, which is an incremental extension. The hypothesis reads as "applying known lamin A/C mechanobiology to mechanoenhancers" rather than a genuine cross-domain insight.

---

## HYPOTHESIS: C2-H3 — Nuclear Actin Polymerization State Regulates MRTF-A Residence Time at CaRG-Box Mechanoenhancers

**VERDICT: KILLED**
**REVISED CONFIDENCE: 1/10** (down from 0.60)

### ATTACKS

**1. Novelty Kill**
- Search: `nuclear F-actin MRTF-A RPEL domain chromatin tether dwell time formin`
- Result: No published work proposes RPEL-mediated F-actin tethering of MRTF-A at chromatin. This appears novel — but see Hallucination-as-Novelty check below.
- **Finding: Appears "novel" — but novel because it's wrong (see Attack 8).**

**2. Mechanism Kill — CRITICAL FAILURE**
- The core mechanism claims: "nuclear F-actin cables → MRTF-A RPEL domain contacts nuclear F-actin → MRTF-A dwell time at CaRG-box chromatin increases."
- **This is structurally impossible.** The RPEL domain binds **G-actin (monomeric actin) exclusively**, NOT F-actin (filamentous actin). Structural studies are unambiguous:
  - Mouilleron et al. (EMBO J 2008, [PMC2583105](https://pmc.ncbi.nlm.nih.gov/articles/PMC2583105/)): Crystal structure of RPEL-actin complexes shows "the actin orientations and interactions in the RPEL assemblies are **not related to those in F-actin**, and it therefore would appear **unlikely that RPEL domains would bind filamentous actin effectively**."
  - Mouilleron et al. (Science Signaling 2011): Pentavalent G-actin•RPEL complex structure shows each RPEL motif binds actin at the hydrophobic cleft (subdomain 1/3 interface), forming an assembly "**distinctively different from that of F-actin**."
- **The actual mechanism is the OPPOSITE of what C2-H3 claims:** Nuclear F-actin polymerization depletes nuclear G-actin → G-actin releases from RPEL → MRTF-A RPEL domain becomes unoccupied → MRTF-A can bind chromatin. F-actin doesn't tether MRTF-A; its effect is **indirect** via G-actin pool depletion. This is the established model confirmed by multiple groups (Miralles 2003 Cell, Baarlink 2013 Science, Vartiainen 2007, Mouilleron 2008/2011).
- **FINDING: MECHANISM KILL — RPEL-F-actin binding is structurally impossible. The entire mechanistic chain collapses.**

**3. Logic Kill**
- The hypothesis confuses two distinct mechanisms: (1) RPEL binding G-actin (which controls MRTF-A localization) and (2) nuclear F-actin formation (which depletes G-actin). It incorrectly synthesizes these into "F-actin tethers MRTF-A via RPEL" — a logical error of conflation.
- **Finding: LOGICAL CONFLATION — two independent mechanisms incorrectly merged.**

**4. Falsifiability Kill**
- The proposed experiments (SMIFH2, Latrunculin A, SPT) are technically feasible, but they would test the wrong mechanism. SMIFH2 on stiff ECM would reduce MRTF-A at CaRG-box loci — but via reduced nuclear G-actin depletion (maintaining RPEL-G-actin export), NOT via reduced F-actin tethering. The experiment cannot discriminate the proposed (wrong) mechanism from the established (correct) mechanism.
- **Finding: WOUNDED — experiments are interpretable under the correct mechanism, making the proposed mechanism unfalsifiable by the proposed tests.**

**5. Triviality Kill**
- N/A (mechanism is wrong).

**6. Counter-Evidence Search**
- Search: `MRTF nuclear retention mechanism G-actin nuclear export actin polymerization depletes monomeric`
- Found: Nat Commun 2021 ([PMC8613289](https://pmc.ncbi.nlm.nih.gov/articles/PMC8613289/)): "Nuclear-capture of endosomes depletes nuclear G-actin to promote SRF/MRTF activation" — confirms that MRTF activation in the nucleus depends on nuclear G-actin depletion, NOT F-actin tethering.
- Found: "Once in the nucleus, G-actin levels must be kept low within this compartment for MRTF's RPEL domains to mediate binding to its target promoter regions" — MRTF chromatin binding requires G-actin-free RPEL, not F-actin-bound RPEL.
- **Finding: DIRECT COUNTER-EVIDENCE — established mechanism is G-actin depletion, not F-actin tethering.**

**7. Groundedness Attack**
- Nuclear actin polymerization under mechanical stimulation: **GROUNDED** — Baarlink 2013 Science ([DOI: 10.1126/science.1235038](https://www.science.org/doi/10.1126/science.1235038)).
- mDia1 formin promotes nuclear actin polymerization: **GROUNDED** — Baarlink 2013.
- MRTF-A RPEL domain binds G-actin: **GROUNDED** — Miralles 2003 Cell ([PMID 12732141](https://pubmed.ncbi.nlm.nih.gov/12732141/)).
- "Nuclear F-actin tethers MRTF-A at CaRG-box mechanoenhancers via RPEL domain": **FABRICATED PROTEIN PROPERTY** — RPEL does not bind F-actin. Structural studies explicitly rule this out.
- mDia1/FHOD3 formin activity in nucleus: **PARTIALLY GROUNDED** — mDia1 is a nuclear formin (confirmed). FHOD3 is primarily an outer nuclear membrane/perinuclear formin tethered to nesprins of the LINC complex ([Frontiers 2023](https://www.frontiersin.org/journals/cell-and-developmental-biology/articles/10.3389/fcell.2023.1160219/full)), NOT a nuclear interior actin polymerizer in fibroblasts. FHOD3 has "strong F-actin bundling activity and relatively weak actin polymerization activity."
- **Groundedness: ~50% verified, but the CRITICAL inferred claim is structurally impossible.**

**8. Hallucination-as-Novelty Check — POSITIVE**
- **This is hallucination masquerading as novelty.** The hypothesis seems novel because no one has proposed RPEL-mediated F-actin tethering at mechanoenhancers. The reason no one has proposed it is that structural biology explicitly demonstrates it cannot happen — RPEL domains bind G-actin at surfaces incompatible with F-actin geometry.
- The bridge mechanism (RPEL binding F-actin) does NOT exist independently of the hypothesis. The RPEL domain's only established interaction with actin is with G-actin (monomeric form). The hypothesis attributes a fabricated property to the RPEL domain.
- **FINDING: HALLUCINATION-AS-NOVELTY CONFIRMED — "novelty" is an artifact of a fabricated protein property.**

**9. Claim-Level Fact Verification — CRITICAL FAILURE**
- Baarlink 2013 Science: ✓ Verified — real paper, nuclear actin polymerization by formins
- mDia1 nuclear formin: ✓ Verified
- Miralles 2003 Cell: ✓ Verified — real paper, RPEL/G-actin mechanism ([PMID 12732141](https://pubmed.ncbi.nlm.nih.gov/12732141/))
- RPEL domain binds G-actin: ✓ Verified — but the hypothesis MISAPPLIES this to claim RPEL binds F-actin
- **RPEL-F-actin interaction: ✗ FABRICATED** — structural studies (EMBO J 2008, Science Signaling 2011) explicitly show RPEL-actin complex is geometrically incompatible with F-actin. The hypothesis correctly cites the RPEL-G-actin papers but then fabricates a RPEL-F-actin property that these same papers refute.
- FHOD3 nuclear formin in fibroblasts: ✗ INCORRECT — FHOD3 is perinuclear (outer nuclear membrane/LINC complex), not nuclear interior. Nuclear actin polymerizers in fibroblasts are mDia1/mDia2.
- **FINDING: TWO FABRICATED/INCORRECT CLAIMS — (1) RPEL-F-actin binding, (2) FHOD3 as nuclear interior formin. Grounds for KILL.**

### SURVIVAL NOTE
C2-H3 does not survive. The single strongest reason it is killed: the RPEL domain's structural biology is crystal clear — it binds G-actin monomers at an interface incompatible with F-actin filaments (EMBO J 2008, Science Signaling 2011). The entire mechanistic chain depends on this fabricated protein property. Additionally, FHOD3 is mischaracterized as a nuclear interior formin when it is actually a perinuclear/outer nuclear membrane formin. The proposed dwell-time experiments would yield results interpretable under the correct mechanism (G-actin depletion → RPEL release → chromatin binding), making the hypothesis unfalsifiable by its own tests.

**Note to Generator**: The CONCEPT that stiffness affects MRTF-A chromatin residence time is potentially worth exploring, but through the CORRECT mechanism: nuclear F-actin polymerization depletes nuclear G-actin → G-actin releases from RPEL → unoccupied RPEL allows MRTF-A-SRF stable chromatin association. This is a different hypothesis with different predictions than what C2-H3 proposes.

---

## META-CRITIQUE

### Kill Rate Assessment
- **Kill rate: 1/3 = 33%** — within the healthy range (30-50%).
- C2-H1 SURVIVES with strong mechanistic support (BRD4 nucleation literature).
- C2-H2 WOUNDED with severe novelty reduction (core concept published 2024).
- C2-H3 KILLED by fabricated protein property (RPEL-F-actin binding).

### Strongest Reason C2-H1 Should Have Been Killed But Wasn't
The CaMKII→HDAC4→EP300 chain is established in cardiomyocytes under pressure overload, not in lung fibroblasts on hydrogels. Cell-type translation may fail — CaMKII isoform expression (CaMKIIδ vs CaMKIIα) and HDAC4 levels may differ. However, this is an empirical uncertainty, not a structural impossibility.

### Strongest Reason C2-H2 Should Have Been Killed But Wasn't
The 2024 Nat Comms paper essentially demonstrates the thesis. The only novel element (mechanoenhancer H3K27ac) is a small incremental step. One could argue this is below the novelty threshold for a genuine discovery. It survives as WOUNDED because the specific H3K27ac prediction at mechanoenhancers is untested and the experimental design (scCUT&RUN + lamin A correlation) is well-specified.

### Web Search Verification
- C2-H1: ✓ Novelty search, BRD4 condensate search, Piezo1-CaMKII search, Zanconato 2018 verification, Backs 2006 verification, PMID 23804765 retraction check
- C2-H2: ✓ Novelty search, lamin A/C-YAP threshold search, Swift 2013 verification, counter-evidence search, cell-to-cell heterogeneity search
- C2-H3: ✓ RPEL-G-actin specificity search, RPEL-F-actin binding impossibility search, Baarlink 2013 verification, Miralles 2003 verification, FHOD3 nuclear localization search, MRTF nuclear retention mechanism search, SRF/MRTF dwell time SPT search

### Claim-Level Verification (v5.4 Mandatory)
- C2-H1: All [GROUNDED] claims verified. PMID 23804765 (retracted) flagged in QG evidence — does not affect hypothesis.
- C2-H2: All [GROUNDED] claims verified. No citation hallucinations.
- C2-H3: **TWO FABRICATED CLAIMS DETECTED** — (1) RPEL-F-actin binding, (2) FHOD3 as nuclear interior formin. KILL justified.

### Critic Questions for Generator (Cycle 3, if applicable)

1. **CQ-C2-1** (applies to C2-H1): What is the evidence for CaMKIIδ expression and HDAC4 protein levels in primary human lung fibroblasts? The CaMKII→HDAC4 pathway is characterized in cardiomyocytes — does this cell-type translation hold?

2. **CQ-C2-2** (applies to C2-H1): EP300 "freeing" by HDAC4/5 export is oversimplified. Class IIa HDACs repress via NCoR/SMRT/HDAC3 complexes, not by directly inhibiting EP300. What is the specific mechanism by which HDAC4 export leads to EP300 recruitment at mechanoenhancers?

3. **CQ-C2-3** (applies to C2-H2): The 2024 Nat Comms paper demonstrates lamin A/C tension → YAP threshold. How does C2-H2 advance beyond this published result? What specific prediction distinguishes C2-H2 from the known mechanism?

---

## Summary Table

| Hypothesis | Verdict | Confidence | Key Attack | Core Issue |
|---|---|---|---|---|
| C2-H1 | SURVIVES | 6/10 | All 9 ✓ | BRD4 nucleation confirmed; cell-type translation concern |
| C2-H2 | WOUNDED | 4/10 | Novelty Kill | Core concept published (2024 Nat Comms); incremental extension |
| C2-H3 | KILLED | 1/10 | Mechanism Kill + Hallucination-as-Novelty | RPEL-F-actin binding structurally impossible; fabricated protein property |
